U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2020
742
Substance Class Protein
Created
by admin
on Sat Dec 16 15:11:45 GMT 2023
Edited
by admin
on Sat Dec 16 15:11:45 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
TG8IQ19NG2
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
ANSUVIMAB
USAN  
Official Name English
VRC-EBOMAB092-00-AB
Code English
ansuvimab [INN]
Common Name English
Ansuvimab [WHO-DD]
Common Name English
MAB114
Code English
ANSUVIMAB [USAN]
Common Name English
ANTI-EBOLA MONOCLONAL ANTIBODY MAB114
Common Name English
EVB114
Code English
MAB-114
Code English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(ZAIRE EBOLAVIRUS ENVELOPE GLYCOPROTEIN GP1 SUBUNIT GLYCAN CAP DOMAIN(SUBUNIT (III))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-449) (HOMO SAPIENS VH (IGHVV3-13*01 (78%) (IGHD)-IGHJ5*01 (93%)) (8.7.13) (1-119)-HOMO SAPI
Common Name English
EVB-114
Code English
IMMUNOGLOBULIN G1, ANTI-(ZAIRE EBOLAVIRUS GLYCOPROTEIN GLYCAN CAP AND GP1 DOMAIN) (HUMAN MONOCLONAL MAB114 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MAB114 .KAPPA.-CHAIN, DIMER
Common Name English
EBOV MAB114
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 683019
Created by admin on Sat Dec 16 15:11:45 GMT 2023 , Edited by admin on Sat Dec 16 15:11:45 GMT 2023
FDA ORPHAN DRUG 730820
Created by admin on Sat Dec 16 15:11:45 GMT 2023 , Edited by admin on Sat Dec 16 15:11:45 GMT 2023
Code System Code Type Description
CAS
2375952-29-5
Created by admin on Sat Dec 16 15:11:45 GMT 2023 , Edited by admin on Sat Dec 16 15:11:45 GMT 2023
PRIMARY
INN
11568
Created by admin on Sat Dec 16 15:11:45 GMT 2023 , Edited by admin on Sat Dec 16 15:11:45 GMT 2023
PRIMARY
DAILYMED
TG8IQ19NG2
Created by admin on Sat Dec 16 15:11:45 GMT 2023 , Edited by admin on Sat Dec 16 15:11:45 GMT 2023
PRIMARY
CAS
2266625-91-4
Created by admin on Sat Dec 16 15:11:45 GMT 2023 , Edited by admin on Sat Dec 16 15:11:45 GMT 2023
SUPERSEDED
FDA UNII
TG8IQ19NG2
Created by admin on Sat Dec 16 15:11:45 GMT 2023 , Edited by admin on Sat Dec 16 15:11:45 GMT 2023
PRIMARY
USAN
HI-98
Created by admin on Sat Dec 16 15:11:45 GMT 2023 , Edited by admin on Sat Dec 16 15:11:45 GMT 2023
PRIMARY
RXCUI
2472152
Created by admin on Sat Dec 16 15:11:45 GMT 2023 , Edited by admin on Sat Dec 16 15:11:45 GMT 2023
PRIMARY
NCI_THESAURUS
C175743
Created by admin on Sat Dec 16 15:11:45 GMT 2023 , Edited by admin on Sat Dec 16 15:11:45 GMT 2023
PRIMARY
WIKIPEDIA
Ansuvimab
Created by admin on Sat Dec 16 15:11:45 GMT 2023 , Edited by admin on Sat Dec 16 15:11:45 GMT 2023
PRIMARY
From To
1_22 1_95
2_22 2_95
2_146 2_202
2_222 4_214
2_263 2_323
1_146 1_202
2_369 2_427
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
1_222 3_214
1_228 2_228
1_231 2_231
1_263 1_323
1_369 1_427
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_299
N 2_299
Related Record Type Details
ANSUVIMAB-ZYKL
SUB_CONCEPT->SUBSTANCE
ZAIRE EBOLAVIRUS
TARGET ORGANISM->INHIBITOR
Related Record Type Details
ANSUVIMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966